Rangers top prospect Josh Jung underwent surgery to repair a torn labrum in his left shoulder Wednesday morning, the team told reporters (Twitter link via Evan Grant of the Dallas Morning News). It’s expected to be about six months before he’s cleared to even begin serving as a designated hitter in games. Jung sustained the injury recently while lifting weights as part of his offseason training regimen. Texas had already shut him down, but the hope was that he could avoid surgery. After receiving additional medical opinions this week, however, surgery was deemed the necessary course of treatment.
It’s a brutal blow for the Rangers, which hoped last year could serve as the final full year of development for Jung. A big league debut at some point in 2022 was widely expected after the 2019 No. 8 overall pick laid waste to Double-A and Triple-A pitching in 2021. In 342 plate appearances between those two levels, Jung slashed a combined .326/.398/.592 with 19 home runs, 22 doubles, a triple, a 22.2% strikeout rate and a 9.1% walk rate.
There was some thought that with a big enough spring showing, Jung could even position himself as a candidate to break camp with the Rangers. Texas is clearly shifting from its prior rebuilding mode into a win-now mindset, as evidenced by the offseason signings of Corey Seager, Marcus Semien and Jon Gray. Jung is the overwhelming favorite to eventually slot in as the team’s everyday third baseman, and most scouting reports on the promising former Texas Tech star expect him to do just that. He ranked as the No. 26 prospect in MLB at Baseball America this winter, No. 31 at Baseball Prospectus and No. 19 at ESPN. The team at FanGraphs was most bullish on Jung, placing a 60 grade on him overall (on the 20-80 scale) and ranking him inside the sport’s 15 best farmhands.
Any coronation of Jung as the team’s everyday third baseman is now on hold for the majority of the 2022 season — if not until the 2023 campaign. With Jung now out of the picture for the foreseeable future, versatile defensive star Isiah Kiner-Falefa finds himself shifting from a super-utility role (and interesting trade candidate) to the team’s primary option at the hot corner.
The 26-year-old Kiner-Falefa is well-equipped to handle such a role, as he proved in 2020 when he won a Gold Glove Award at third base. He moved to shortstop for the 2021 campaign and turned in another strong defensive showing, although the potential drop-off from Jung to Kiner-Falefa from an offensive standpoint is likely to be steep. Talented as he is with the glove, Kiner-Falefa is primarily a singles hitter who rarely walks. He’s posted a .273/.316/.361 batting line over the past two seasons, which is productive enough to provide value when combined with his defensive prowess, but Jung has quite a bit more power and is widely expected to be an impact performer on offense.
Offensive gap between the two notwithstanding, Kiner-Falefa is a solid option to have on hand. He had reportedly been of interest to the Yankees as a possible trade candidate prior to the lockout, but Jung’s injury surely dampens the possibility that the Rangers would consider parting with Kiner-Falefa. While they could, speculatively speaking, still move Kiner-Falefa if a compelling enough offer presents itself and follow that trade with a short-term free agent signing, the likelier scenario is that Kiner-Falefa will be manning the hot corner at Globe Life Field for the vast majority of the 2022 season.
More must-reads: